Sunday, October 18, 2009

Glucokinase activators, new class of drugs for the treatment of type 2 diabetes .....

Glucokinase activators (GKAs) represent a promising new class of drugs for the treatment of type 2 diabetes that act directly on both the pancreas and the liver. Glucokinase (GK) is a key enzyme in glucose-sensing tissues that regulates glucose homeostatasis. GKAs lower glucose levels by enhancing the ability of pancreatic beta cells to “sense glucose” and increase insulin secretion in a glucose-dependent manner. Simultaneously, GKAs increase the uptake and disposal of glucose in the liver, while simultaneously reducing the amount it produces.

For more details, read the link 
Drug Pipeline

Shared via AddThis

1 comment:

haixiao1 said...

GKAs lower glucose levels by enhancing pandora bracelet the ability of pancreatic beta cells to pandora shop “sense glucose” and increase insulin secretion in pandora charms a glucose-dependent manner. Simultaneously, GKAs increase the pandora clips uptake and disposal of glucose in the liver, while simultaneously pandora dangles beads reducing the amount it produces.